Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

LogicBio Therapeutics Inc. (the company became a subdivision of the company AstraZeneca PLC (AZN)) (LOGC)

  • Technical Exchange News
  • May 13, 2024, 07:21 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

LogicBio Therapeutics Inc. (the company became a subdivision of the company AstraZeneca PLC (AZN)) (LOGC)

  • Technical Exchange News
  • May 13, 2024, 07:21 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: -. New value: ContextLogic Inc. - Class A Common Stock.

Comment Full text

NeuBase Therapeutics Inc. (NBSE)

  • Technical Exchange News
  • May 13, 2024, 00:24 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: NeuBase Therapeutics, Inc. - Common Stock.

Comment Full text

NeuBase Therapeutics Inc. (NBSE)

  • Technical Exchange News
  • May 13, 2024, 00:24 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: NeuBase Therapeutics, Inc. - Common Stock. New value: NeuBase Therapeutics, Inc. - Common Stock.

Comment Full text

NeuBase Therapeutics Inc. (NBSE)

  • Technical Exchange News
  • May 13, 2024, 00:24 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: NeuBase Therapeutics, Inc. - Common Stock.

Comment Full text

NeuBase Therapeutics Inc. (NBSE)

  • Technical Exchange News
  • May 11, 2024, 01:39 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Normal.

Comment Full text

ENDRA Life Sciences Inc (NDRA)

  • Technical Exchange News
  • May 11, 2024, 01:39 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

NeuBase Therapeutics Inc. (NBSE)

  • Technical Exchange News
  • May 10, 2024, 19:02 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Normal.

Comment Full text

ENDRA Life Sciences Inc (NDRA)

  • Technical Exchange News
  • May 10, 2024, 19:02 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Jin Medical International Ltd (ZJYL)

  • Technical Exchange News
  • May 10, 2024, 01:51 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text
  • Previous
  • 959
  • 960
  • 961
  • 962
  • 963
  • Next

Search

News categories

  • Technical Exchange News(14591)
  • Event(6229)
  • SEC News(384619)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235046)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin